Evidence map›Paper›PMID 29880566›Full record

ArticleBMJ open2018

Cross-sectional survey on adult acute kidney injury in Chinese ICU: the study protocol (CARE-AKI).

Zhenyu Yang, Cong Wang, Hongliang Wang, Sicong Wang, Ruijin Liu, Xu Wang, Kaijiang Yu

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Zhenyu Yang *Intensive Care Unit, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Cong Wang *Intensive Care Unit, The First Affiliated Hospital of Heilongjiang, University of Chinese Medicine, Harbin, China.
Hongliang WangIntensive Care Unit, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Sicong WangIntensive Care Unit, Cancer Hospital Affiliated to Harbin Medical University, Harbin, China.
Ruijin LiuIntensive Care Unit, Cancer Hospital Affiliated to Harbin Medical University, Harbin, China.
Xu WangIntensive Care Unit, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Kaijiang YuIntensive Care Unit, Cancer Hospital Affiliated to Harbin Medical University, Harbin, China.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CNThird Affiliated Hospital of Harbin Medical University · CNFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcute kidney injury (AKI) is one of the most serious syndromes in intensive care unit (ICU) patients, and is a mysterious problem in clinical practice worldwide. Due to unknown aetiology and mechanism, awareness of AKI diagnosis and treatment in China varies, resulting in underestimated incidence and poor prognosis. To solve this problem, we design this national survey of AKI in adult ICUs. Various indexes are included and analysed to classify the epidemiology of adult AKI in Chinese ICUs, including AKI aetiology, risk factors, mortality, prognosis, therapeutic strategies and cognition of ICU medical staff.

methodsA multicentre, cross-sectional survey, which will involve about 35 hospitals and 6147 patients from 23 provinces, 4 municipalities and 5 autonomous regions, is planned. All patients who meet the inclusion criteria are eligible to apply for enrolment in the study, which cover baseline demographics, clinical performance, and follow-up related to diagnosis and treatment.

conclusionThe study is expected to fill the gap between China and developed countries, and to provide a theoretical foundation for developing more scientific and standardised approaches to AKI diagnosis and treatment. ETHICS AND DISSEMINATION: Ethical approval was obtained from the ethics committee of Harbin Medical University Cancer Hospital (registration number KY2017-21). The findings of this review will be communicated through peer-reviewed publications and scientific presentations. TRIAL REGISTRATION NUMBER: ChiCTR-EOC-17013133; Pre-results.

Indexed as

Acute Kidney InjuryAdultChinaCross-Sectional StudiesHospital MortalityHumansIncidenceIntensive Care UnitsMulticenter Studies as TopicPrognosisRandomized Controlled Trials as TopicRisk FactorsSurveys and QuestionnairesTertiary Care Centersacute renal failureauditcross-sectional study

Identifiers

PMID29880566
PMCPMC6009469
OpenAlexW2806093910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.